Associated Papers
Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.
Gong M et al.
Oncotarget, 2017
Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases.
Langsenlehner U et al.
Acta Oncologica (stockholm, Sweden), 2015
The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.
Rahoui J et al.
Medical Oncology (northwood, London, England), 2014
The role of vascular endothelial growth factor a polymorphisms in breast cancer.
Sa-Nguanraksa D et al.
International Journal of Molecular Sciences, 2012
Revaluation of the association between vascular endothelial growth factor gene 936 C/T polymorphism and breast cancer risk.
Jin B et al.
Breast Cancer Research and Treatment, 2011
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
Etienne-Grimaldi MC et al.
British Journal of Clinical Pharmacology, 2011
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
Jin Q et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2005
Select a paper to view details